Analysts expect Anika Therapeutics, Inc. to report revenue of 28.57 M for Q3 26, against a range of 27.37 M to 29.77 M. The most recent reported quarter, Q2 26, came in at 32.61 M, a 18.2% beat against the 27.59 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 38.75 M | 30.60 M | 26.17 M | 28.22 M | 27.82 M | 30.61 M | 29.61 M | 32.61 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 48.30 M | 32.01 M | 28.41 M | 29.93 M | 32.08 M | 33.15 M | 30.97 M | 29.30 M | 29.77 M | 33.89 M | 30.98 M | 32.67 M | 32.83 M | 32.59 M | 36.75 M | 38.81 M | ||||||||||
| Low Estimate | 41.31 M | 28.98 M | 26.29 M | 26.50 M | 27.18 M | 27.35 M | 28.98 M | 25.88 M | 27.37 M | 30.10 M | 27.06 M | 29.18 M | 30.59 M | 29.95 M | 33.42 M | 33.35 M | ||||||||||
| Consensus Estimate | 44.81 M | 30.50 M | 27.35 M | 28.21 M | 29.63 M | 30.25 M | 29.98 M | 27.59 M | 28.57 M | 32.00 M | 29.02 M | 30.92 M | 31.71 M | 31.27 M | 35.08 M | 36.08 M |
Analysts expect Anika Therapeutics, Inc. to report earnings per share of 0.44 for Q3 26, against a range of 0.42 to 0.46. The most recent reported quarter, Q2 26, came in at 0.42 , in line with the 0.03 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.25 | -0.03 | -0.06 | -0.13 | 0.04 | 0.31 | 0.27 | 0.42 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 0.09 | -0.20 | -0.08 | -0.27 | -0.18 | -0.13 | 0.00 | 0.03 | 0.46 | 0.21 | 0.23 | 0.36 | 0.52 | 0.35 | 0.15 | 0.26 | ||||||
| Low Estimate | 0.07 | -0.24 | -0.10 | -0.29 | -0.20 | -0.15 | 0.00 | 0.03 | 0.42 | 0.17 | 0.19 | 0.32 | 0.42 | 0.31 | 0.13 | 0.22 | ||||||
| Consensus Estimate | 0.08 | -0.22 | -0.09 | -0.28 | -0.19 | -0.14 | 0.00 | 0.03 | 0.44 | 0.19 | 0.21 | 0.34 | 0.47 | 0.33 | 0.14 | 0.24 |
Pull Wall Street consensus for Anika Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ANIK&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ANIK", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ANIK&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();